- Home
- SNBR vs NBY Comparison
SNBR vs NBY Comparison
Compare SNBR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- NBY
- Stock Information
- Founded
- SNBR 1987
- NBY 2000
- Country
- SNBR United States
- NBY United States
- Employees
- SNBR N/A
- NBY N/A
- Industry
- SNBR Home Furnishings
- NBY
- Sector
- SNBR Consumer Discretionary
- NBY
- Exchange
- SNBR Nasdaq
- NBY Nasdaq
- Market Cap
- SNBR N/A
- NBY 3.5M
- IPO Year
- SNBR 1998
- NBY 2007
- Fundamental
- Price
- SNBR $16.61
- NBY $0.69
- Analyst Decision
- SNBR Hold
- NBY
- Analyst Count
- SNBR 3
- NBY 0
- Target Price
- SNBR $14.17
- NBY N/A
- AVG Volume (30 Days)
- SNBR 460.0K
- NBY 7.7M
- Earning Date
- SNBR 11-05-2024
- NBY 11-07-2024
- Dividend Yield
- SNBR N/A
- NBY N/A
- EPS Growth
- SNBR N/A
- NBY N/A
- EPS
- SNBR N/A
- NBY N/A
- Revenue
- SNBR $1,781,028,000.00
- NBY $13,884,000.00
- Revenue This Year
- SNBR N/A
- NBY N/A
- Revenue Next Year
- SNBR $2.90
- NBY $26.04
- P/E Ratio
- SNBR N/A
- NBY N/A
- Revenue Growth
- SNBR N/A
- NBY 4.06
- 52 Week Low
- SNBR $8.13
- NBY $0.36
- 52 Week High
- SNBR $22.36
- NBY $15.40
- Technical
- Relative Strength Index (RSI)
- SNBR 50.79
- NBY 53.60
- Support Level
- SNBR $16.35
- NBY $0.64
- Resistance Level
- SNBR $18.34
- NBY $0.75
- Average True Range (ATR)
- SNBR 1.28
- NBY 0.08
- MACD
- SNBR -0.21
- NBY 0.02
- Stochastic Oscillator
- SNBR 19.61
- NBY 39.04
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.